Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.32B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$2.19B |
| 3 |
Apple
AAPL
|
+$2.17B |
| 4 |
NVIDIA
NVDA
|
+$2.12B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$563M |
| 2 |
Jefferies Financial Group
JEF
|
+$510M |
| 3 |
SPDR Gold Trust
GLD
|
+$313M |
| 4 |
S&P Global
SPGI
|
+$286M |
| 5 |
CrowdStrike
CRWD
|
+$196M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.69% |
| 2 | Consumer Discretionary | 7.38% |
| 3 | Financials | 7.04% |
| 4 | Healthcare | 5.93% |
| 5 | Communication Services | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4651
Invesco Preferred ETF
PGX
$3.81B
| $61.7K | ﹤0.01% |
5,500
-40
| -0.7% | -$463 |
|
|
SGMO
4652
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $61.6K | ﹤0.01% |
93,879
-61,007
| -39% | -$64.6K |
|
4653
Pliant Therapeutics
PLRX
$66.3M
| $61.5K | ﹤0.01% |
45,543
-7,038
| -13% | -$42.7K |
|
|
QIPT
4654
DELISTED
Quipt Home Medical
QIPT
| $61.4K | ﹤0.01% |
26,460
-5,935
| -18% | -$16.3K |
|
4655
Geospace Technologies
GEOS
$88.4M
| $61.1K | ﹤0.01% |
8,472
-6,867
| -45% | -$58.9K |
|
4656
Sight Sciences
SGHT
$288M
| $60.8K | ﹤0.01% |
25,354
-3,207
| -11% | -$9.03K |
|
|
DOYU
4657
DouYu International Holdings
DOYU
$140M
| $60.5K | ﹤0.01% |
8,097
-159
| -2% | -$1.82K |
|
4658
eGain
EGAN
$190M
| $60.4K | ﹤0.01% |
12,451
-1,547
| -11% | -$8.76K |
|
4659
ARK Blockchain & Fintech Innovation ETF
ARKF
$744M
| $59.9K | ﹤0.01% |
1,800
-3,899
| -68% | -$150K |
|
4660
First Trust Europe AlphaDEX Fund
FEP
$515M
| $59.7K | ﹤0.01% |
1,463
+5
| +0.3% | +$196 |
|
4661
BRC Group Holdings
RILY
$270M
| $59.7K | ﹤0.01% |
15,431
-1,197
| -7% | -$5.43K |
|
4662
Northern Technologies International Corp
NTIC
$76.4M
| $59.5K | ﹤0.01% |
5,715
-599
| -9% | -$7.02K |
|
4663
Atossa Therapeutics
ATOS
$24.1M
| $59.3K | ﹤0.01% |
5,872
-796
| -12% | -$9.66K |
|
4664
Scilex Holding
SCLX
$48M
| $59K | ﹤0.01% |
6,789
-290
| -4% | -$3.64K |
|
4665
Twin Disc
TWIN
$333M
| $58.7K | ﹤0.01% |
7,750
-858
| -10% | -$8.33K |
|
4666
Caribou Biosciences
CRBU
$148M
| $58.4K | ﹤0.01% |
63,919
-11,856
| -16% | -$15.4K |
|
4667
MacroGenics
MGNX
$245M
| $58.2K | ﹤0.01% |
45,857
-4,292
| -9% | -$11.2K |
|
|
FSFG
4668
DELISTED
First Savings Financial Group
FSFG
| $58.2K | ﹤0.01% |
2,260
-3,478
| -61% | -$87.2K |
|
4669
Lineage Cell Therapeutics
LCTX
$267M
| $57.9K | ﹤0.01% |
128,102
+6,249
| +5% | +$3.67K |
|
|
OS
4670
DELISTED
OneStream Inc
OS
| $57.7K | ﹤0.01% |
2,706
-8,982
| -77% | -$230K |
|
4671
Gilat Satellite Networks
GILT
$812M
| $57.7K | ﹤0.01% |
9,142
+7,292
| +394% | +$50.7K |
|
4672
Trinity Capital Inc.
TRIN
$1.59B
| $57.7K | ﹤0.01% |
+3,804
| New | +$59.1K |
|
|
IRBT
4673
DELISTED
iRobot
IRBT
| $57.6K | ﹤0.01% |
21,348
-2,050
| -9% | -$14.8K |
|
|
SMC
4674
Summit Midstream
SMC
$412M
| $57.5K | ﹤0.01% |
1,696
-31,567
| -95% | -$1.27M |
|
4675
Tango Therapeutics
TNGX
$4.34B
| $57.3K | ﹤0.01% |
41,823
-5,169
| -11% | -$12.7K |
|
Similar funds
Citigroup's Q1 2025 Portfolio in Review
As of Q1 2025, Citigroup held 6,124 positions worth $196B, up 16% from $169B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citigroup deployed $38.1B of net new capital in Q1 2025, opening 294 new positions and adding to 2,193 existing holdings. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 2,013,956 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares China Large-Cap ETF, an estimated $563M trimmed.
- Citigroup's largest Q1 2025 buy was Boeing Co 6.00% Series A Preferred Stock: 2,013,956 shares worth $120M.
- Citigroup added most to Microsoft in Q1 2025, an estimated $2.32B increase.
- Citigroup's biggest Q1 2025 reduction was iShares China Large-Cap ETF, cutting an estimated $563M.
- Citigroup fully exited Retail Opportunity Investments Corp. in Q1 2025, selling an estimated $46.9M.
- Citigroup's ten largest holdings make up 24% of its $196B portfolio in Q1 2025.
- Citigroup opened 294 new positions and closed 585 in Q1 2025.
- Citigroup's portfolio value rose 16% quarter-over-quarter to $196B.
Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.